|
1
|
Zhao BB, Yang ZJ, Wang Q, Pan ZM, Zhang W
and Li L: Clinical validation of multiple biomarkers suspension
array technology for ovarian cancer. Zhonghua Fu Chan Ke Za Zhi.
52:11–19. 2017.(In Chinese). PubMed/NCBI
|
|
2
|
Hennessy BT, Coleman RL and Markman M:
Ovarian cancer. Lancet. 374:1371–1382. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dubosq F, Ploussard G, Soliman H, Turpin
E, Latil A, Desgrandchamps F, de The H and Mongiat-Artus P:
Identification of a three-gene expression signature of early
recurrence in non-muscle-invasive urothelial cell carcinoma of the
bladder. Urol Oncol. 30:833–840. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cho KR and Shih IeM: Ovarian cancer. Annu
Rev Pathol. 4:287–313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology, and prognostic factors. Semin Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gorelik E, Landsittel DP, Marrangoni AM,
Modugno F, Velikokhatnaya L, Winans MT, Bigbee WL, Herberman RB and
Lokshin AE: Multiplexed immunobead-based cytokine profiling for
early detection of ovarian cancer. Cancer Epidemiol Biomarkers
Prev. 14:981–987. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mazzucchelli I, Avanzini MA, Ciardelli L,
Pagani S, Greco R, Belloni C, Castellazzi A, Marconi M, Rondini G
and Polatti F: Human amniotic fluid cells are able to produce IL-6
and IL-8. Am J Reprod Immunol. 51:198–203. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gorelik E, Landsittel DP, Marrangoni AM,
Modugno F, Velikokhatnaya L, Winans MT, Bigbee WL, Herberman RB and
Lokshin AE: Multiplexed immunobead-based cytokine profiling for
early detection of ovarian cancer. Cancer Epidemiol Biomarkers
Prev. 14:981–987. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duan ZG and Yang WM: Analysis of cytokines
(IL-2, IL-8, IL-10) in the expressed prostatic secretions of
chronic prostatitis. Zhonghua Nan Ke Xue. 11:201–203. 2005.(In
Chinese). PubMed/NCBI
|
|
10
|
Redford PS, Murray PJ and O'Garra A: The
role of IL-10 in immune regulation during M. tuberculosis
infection. Mucosal Immunol. 4:261–270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Charbonneau B, Goode EL, Kalli KR, Knutson
KL and Derycke MS: The immune system in the pathogenesis of ovarian
cancer. Crit Rev Immunol. 33:137–164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Block MS, Maurer MJ, Goergen K, Kalli KR,
Erskine CL, Behrens MD, Oberg AL and Knutson KL: Plasma immune
analytes in patients with epithelial ovarian cancer. Cytokine.
73:108–113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vergote I, Rustin GJ, Eisenhauer EA,
Kristensen GB, Pujade-Lauraine E, Parmar MK, Friedlander M,
Jakobsen A and Vermorken JB: Re: New guidelines to evaluate the
response to treatment in solid tumors [ovarian cancer]. Gynecologic
Cancer Intergroup. J Natl Cancer Inst. 92:1534–1535. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiong W, Cao LL, Jiang LP, Xia H and Liang
ZQ: Clinical comparative analysis of comprehensive laparoscopic and
laparotomic staging of early-stage epithelial ovarian cancer.
Zhonghua Fu Chan Ke Za Zhi. 52:103–109. 2017.(In Chinese).
PubMed/NCBI
|
|
15
|
Lokshin AE, Winans M, Landsittel D,
Marrangoni AM, Velikokhatnaya L, Modugno F, Nolen BM and Gorelik E:
Circulating IL-8 and anti-IL-8 autoantibody in patients with
ovarian cancer. Gynecol Oncol. 102:244–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Keefe GM, Nguyen VT and Benveniste EN:
Class II transactivator and class II MHC gene expression in
microglia: Modulation by the cytokines TGF-beta, IL-4, IL-13 and
IL-10. Eur J Immunol. 29:1275–1285. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lane D, Matte I, Rancourt C and Piché A:
Prognostic significance of IL-6 and IL-8 ascites levels in ovarian
cancer patients. BMC Cancer. 11:210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang T, Ma Z, Wang R, Wang Y, Wang S,
Cheng Z, Xu H, Jin X, Li W and Wang X: Thrombin facilitates
invasion of ovarian cancer along peritoneum by inducing monocyte
differentiation toward tumor-associated macrophage-like cells.
Cancer Immunol Immunother. 59:1097–1108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nishio H, Yaguchi T, Sugiyama J, Sumimoto
H, Umezawa K, Iwata T, Susumu N, Fujii T, Kawamura N, Kobayashi A,
et al: Immunosuppression through constitutively activated NF-κB
signalling in human ovarian cancer and its reversal by an NF-κB
inhibitor. Br J Cancer. 110:2965–2974. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matte I, Lane D, Laplante C, Rancourt C
and Piché A: Profiling of cytokines in human epithelial ovarian
cancer ascites. Am J Cancer Res. 2:566–580. 2012.PubMed/NCBI
|
